The Life Sciences Report

Streetwise Reports

The Gold Report

The Energy Report

The Life Sciences Report

Research Reports

Featured news in The Life Sciences Report

Mesoblast Ltd. (MESO:NASDAQ; MSB:ASX)
Mesoblast Resubmits Biologics License Application (BLA) with United States Food & Drug Administration (FDA) for Approval of Ryoncil® in Children with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD) (7/8/2024)

view